J Clin Med Res

Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access

Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc

Journal website http://www.jocmr.org

Original Article

Volume 9, Number 12, December 2017, pages 994-997

A Comparison of the Effects and Side Effects of Oral Betahistine with Injectable Promethazine in the Treatment of Acute Peripheral Vertigo in Emergency

Tables

**Table 1.** Patient’s Characteristics
Variables	Group A (n = 82)	Group B (n = 80)	P value
Age (range)	43.5 (19 - 64)	40.1 (17 - 66)	NS
Gender
Female	45 (54.9%)	42 (52.5%)	NS
Male	37 (45.1%)	38 (47.5%)	NS

**Table 2.** Comparison of Pain Level at Different Times in Both Group A and B
Variable	Time	Group A (n = 82)	Group B (n = 80)	P value
VAS: visual analog scale.
VAS (mean ± SD)	Before intervention	6.26 ± 1.22	6.44 ± 0.6	NS
	1 h	5.09 ± 1.39	4.84 ± 1.14	NS
	2 h	4.28 ± 1.3	3.38 ± 0.98	0.043
	3 h	3.39 ± 1.3	2.7 ± 0.75	0.039
Vertigo after intervention (h)		1.7 ± 0.59	1.6 ± 0.39	NS

**Table 3.** Clinical Pictures During the Study in Group A and Group B
Time	Clinical symptoms	Group A (n = 82)	Group B (n = 80)	P value
Before intervention	Tinnitus	76 (92.7%)	79 (98.8%)	NS
	Nausea and vomiting	6 (7.3%)	1 (1.3%)
1 h	Tinnitus	7 (8.5%)	5 (6.3%)	0.0298
	Nausea and vomiting	39 (47.6%)	52 (65%)
	Drowsiness	17 (20.7%)	0
	None	19 (23.2%)	23 (28.8%)
2 h	Tinnitus	1 (1.2%)	5 (6.3%)	0.0412
	Nausea and vomiting	11 (13.4%)	28 (35%)
	Drowsiness	54 (65.9%)	0
	Cardiac arrhythmia	0	1 (1.3%)
	None	16 (19.5%)	46 (57.5%)
3 h	Tinnitus	1 (1.2%)	3 (3.8%)	0.0398
	Nausea and vomiting	3 (3.7%)	11 (13.8%)
	Drowsiness	51 (62.2%)	0
	Cardiac arrhythmia	0	1 (1.3%)
	None	27 (32.9%)	65 (81.3%)

**Table 4.** Adverse Effect Incidence in Both Group A and Group B
Adverse effect	Group A (n = 82)	Group B (n = 80)	P value
Restlessness	11 (13.4%)	0	0.038
Anxiety	2 (2.4%)	0
Drowsiness	63 (76.8%)	0
None	6 (7.3%)	80 (100%)